Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 335.56B | 322.65B | 319.50B | 349.64B | 300.92B | 282.33B |
Gross Profit | 69.87B | 65.32B | 87.42B | 124.98B | 88.95B | 85.35B |
EBITDA | 44.76B | 53.28B | 66.83B | 99.43B | 69.75B | 64.61B |
Net Income | 12.81B | 8.32B | 23.22B | 54.36B | 28.61B | 18.02B |
Balance Sheet | ||||||
Total Assets | 595.58B | 579.69B | 503.46B | 474.52B | 404.64B | 343.12B |
Cash, Cash Equivalents and Short-Term Investments | 82.50B | 102.78B | 87.20B | 92.57B | 84.30B | 59.62B |
Total Debt | 164.45B | 148.84B | 98.94B | 72.98B | 73.75B | 56.66B |
Total Liabilities | 260.27B | 249.59B | 184.99B | 174.24B | 160.70B | 132.67B |
Stockholders Equity | 335.31B | 330.10B | 318.48B | 300.29B | 243.94B | 210.45B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -28.80B | -23.88B | 15.76B | 8.97B | 8.37B |
Operating Cash Flow | 0.00 | 51.10B | 39.46B | 67.31B | 52.88B | 52.43B |
Investing Cash Flow | 0.00 | -82.79B | -60.44B | -50.62B | -42.22B | -40.87B |
Financing Cash Flow | 0.00 | 37.65B | 14.48B | -14.71B | 12.60B | -4.85B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $4.09B | 53.75 | 5.02% | ― | 11.65% | ― | |
70 Outperform | $2.55B | 27.12 | 12.33% | 2.63% | 10.78% | 58.82% | |
69 Neutral | $2.45B | 95.93 | 1.44% | ― | -10.37% | -85.11% | |
67 Neutral | $2.10B | 15.46 | 130.19% | ― | -6.53% | 240.56% | |
64 Neutral | $2.23B | 144.47 | 0.65% | 2.48% | -0.71% | ― | |
56 Neutral | $3.16B | 4.94 | -5.68% | 5.81% | 7.96% | -51.05% | |
51 Neutral | $2.16B | 26.74 | -3.14% | 2.51% | -11.31% | -127.88% |